Pluri Inc. (PLUR)

NCM – Real Time Price. Currency in USD

3.54

+0.02 (0.57%)

At close: May 12, 2026, 4:00 PM EDT

3.38

-0.16 (-4.52%)

Pre-market: May 13, 2026, 4:01 AM EDT

22.12.2025

Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved

HAIFA, Israel, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Pluri, Inc. (“Pluri”, the “Company”, “we” or “us”) (Nasdaq, TASE: PLUR), a leading biotechnology company leveraging its proprietary platform for cell-based solutions through a collaborative network of ventures, today announced expansion of its manufacturing agreement signed in 2024 with Remedy Cell Ltd. (“Remedy Cell”), an innovative biopharmaceutical company developing stem cell-derived, cell-free therapeutics for complex fibrotic conditions.

27.11.2025

Plurilock Security Inc. (PLUR:CA) Q3 2025 Earnings Call Transcript

Plurilock Security Inc. ( PLUR:CA ) Q3 2025 Earnings Call November 27, 2025 11:00 AM EST Company Participants Ian Paterson - CEO & Director Scott Meyers - CFO & Corporate Secretary Conference Call Participants Ryan Freemantle Presentation Ryan Freemantle Good morning, and thank you for joining us for Plurilock Securities conference call to discuss its financial results for the quarter ending September 30, 2025. I'm Ryan Freemantle from Sophic Capital, and we handle Plurilock's Investor Relations.

Videos

No Data

There is no data to display

Press releases

22.12.2025

Pluri Inc. (PLUR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Pluri Inc. (PLUR)

Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved

Plurilock Security Inc. (PLUR:CA) Q3 2025 Earnings Call Transcript

Videos

No Data

Press releases

Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved

Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved

Plurilock Security Inc. (PLUR:CA) Q3 2025 Earnings Call Transcript

Videos

No Data

Press releases

Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved

Search stocks

Pluri Inc. (PLUR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Pluri Inc. (PLUR)

Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved

Plurilock Security Inc. (PLUR:CA) Q3 2025 Earnings Call Transcript

Videos

No Data

Press releases

Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved

Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved

Plurilock Security Inc. (PLUR:CA) Q3 2025 Earnings Call Transcript

Videos

No Data

Press releases

Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved